AI assistant
SURMODICS INC — Director's Dealing 2016
Dec 12, 2016
32845_dirs_2016-12-12_e22752f3-9cea-4a4c-9355-342bb08d0eee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2016-12-08
Reporting Person: OLSON CHARLES W (Senior VP & GM, Med Dev)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-12-08 | Common Stock | S | 3699 | $26.0187 | Disposed | 28587 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 800 | Indirect |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2016 and amended on November 22, 2016.
F2: Reflects the weighted average price of 3,699 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 8, 2016 with sale prices ranging from $26 to $26.075 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.